Express Scripts Holding Company (ESRX) Shares Sold by Ladenburg Thalmann Financial Services Inc.

Ladenburg Thalmann Financial Services Inc. lowered its stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 5.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 48,033 shares of the company’s stock after selling 2,696 shares during the period. Ladenburg Thalmann Financial Services Inc.’s holdings in Express Scripts Holding Company were worth $3,309,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Union Bankshares Corp increased its position in shares of Express Scripts Holding Company by 45.1% in the third quarter. Union Bankshares Corp now owns 5,776 shares of the company’s stock valued at $407,000 after buying an additional 1,794 shares during the last quarter. W.G. Shaheen & Associates DBA Whitney & Co increased its position in shares of Express Scripts Holding Company by 1.0% in the third quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 60,812 shares of the company’s stock valued at $4,289,000 after buying an additional 585 shares during the last quarter. One Capital Management LLC increased its position in shares of Express Scripts Holding Company by 0.5% in the third quarter. One Capital Management LLC now owns 30,769 shares of the company’s stock valued at $2,170,000 after buying an additional 163 shares during the last quarter. Algert Global LLC bought a new position in shares of Express Scripts Holding Company during the third quarter valued at $830,000. Finally, Raymond James Trust N.A. increased its position in shares of Express Scripts Holding Company by 0.5% in the third quarter. Raymond James Trust N.A. now owns 21,407 shares of the company’s stock valued at $1,509,000 after buying an additional 113 shares during the last quarter. Hedge funds and other institutional investors own 85.36% of the company’s stock.

Institutional Ownership by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)

Express Scripts Holding Company (NASDAQ:ESRX) opened at 65.09 on Monday. The stock has a market capitalization of $39.43 billion, a PE ratio of 12.08 and a beta of 0.92. Express Scripts Holding Company has a 12 month low of $64.45 and a 12 month high of $80.02. The firm has a 50-day moving average price of $68.74 and a 200 day moving average price of $70.80.

Express Scripts Holding Company (NASDAQ:ESRX) last announced its earnings results on Tuesday, February 14th. The company reported $1.88 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.87 by $0.01. Express Scripts Holding Company had a return on equity of 24.99% and a net margin of 2.70%. The company had revenue of $24.90 billion for the quarter, compared to analyst estimates of $26.31 billion. During the same period in the prior year, the company posted $1.56 EPS. The firm’s quarterly revenue was down 5.0% compared to the same quarter last year. Equities analysts anticipate that Express Scripts Holding Company will post $6.93 earnings per share for the current year.

Your IP Address:

Several brokerages have recently weighed in on ESRX. Sanford C. Bernstein restated an “underperform” rating and set a $59.00 price target on shares of Express Scripts Holding Company in a report on Thursday, December 1st. Vetr upgraded Express Scripts Holding Company from a “hold” rating to a “buy” rating and set a $79.36 price target for the company in a report on Monday, February 27th. Zacks Investment Research downgraded Express Scripts Holding Company from a “buy” rating to a “hold” rating in a report on Thursday, December 15th. Oppenheimer Holdings Inc. restated a “hold” rating on shares of Express Scripts Holding Company in a report on Wednesday, December 14th. Finally, Leerink Swann upgraded Express Scripts Holding Company to a “positive” rating in a report on Tuesday, March 7th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $77.03.

In related news, VP Everett Neville sold 1,123 shares of the company’s stock in a transaction dated Tuesday, January 3rd. The stock was sold at an average price of $69.41, for a total transaction of $77,947.43. Following the transaction, the vice president now directly owns 12,712 shares of the company’s stock, valued at approximately $882,339.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.54% of the company’s stock.

About Express Scripts Holding Company

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

5 Day Chart for NASDAQ:ESRX

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/express-scripts-holding-company-esrx-shares-sold-by-ladenburg-thalmann-financial-services-inc/1708772.html

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *